|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/37 | (2006.01) |
| G01N 33/569 | (2006.01) | ||
| G01N 33/573 | (2006.01) |
| (11) | Number of the document | 3279335 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17178062.0 |
| Date of filing the European patent application | 2012-12-28 | |
| (97) | Date of publication of the European application | 2018-02-07 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-10 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161582339 P | 2011-12-31 | US |
| (72) |
Wang, Joanne, US
Dixit, Anuradha, US
Abel, Kenton, US
Gupta, Swati, US
Fernandez-Salas, Ester, US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | HIGHLY SENSITIVE CELL-BASED ASSAY TO DETECT THE PRESENCE OF ACTIVE BOTULINUM NEUROTOXIN SEROTYPE-A |
| HIGHLY SENSITIVE CELL-BASED ASSAY TO DETECT THE PRESENCE OF ACTIVE BOTULINUM NEUROTOXIN SEROTYPE-A |